PA, I.; R, N.; R, N.; ING, B.; K, T. DIFFERENCE IN BLOOD FUNCTION TOXICITY BETWEEN STADIUM IIB-IIIB SQUAMOUS CELL CERVICAL CANCER PATIENTS WITH PACLITAXEL CISPLATIN AND PACLITAXEL CARBOPLATIN CHEMOTHERAPY AT SANGLAH HOSPITAL, DENPASAR. Asian Journal of Pharmaceutical and Clinical Research, [S. l.], v. 11, n. 1, p. 224–227, 2018. DOI: 10.22159/ajpcr.2018.v11i1.22125. Disponível em: https://journals.innovareacademics.in/index.php/ajpcr/article/view/22125. Acesso em: 4 may. 2024.